Combined Etanercept, GAD‐alum and vitamin D treatment: an open pilot trial to preserve beta cell function in recent onset type 1 diabetes

Author:

Ludvigsson Johnny1ORCID,Routray Indusmita2,Vigård Tore34,Hanås Ragnar56,Rathsman Björn7,Carlsson Annelie89,Särnblad Stefan10,Albin Anna‐Karin11,Arvidsson Carl‐Göran12,Samuelsson Ulf1,Casas Rosaura2

Affiliation:

1. Department of Biomedical and Clinical Sciences Crown Princess Victoria Children´s Hospital and Division of Pediatrics Linköping University Linköping Sweden

2. Department of Biomedical and Clinical Sciences Division of Pediatrics Linköping University Linköping Sweden

3. Department of Clinical Sciences Pediatric Endocrinology Lund University Malmö Sweden

4. Department of Pediatrics Skåne University Hospital Malmö Sweden

5. Department of Pediatrics NU Hospital Group Uddevalla Sweden

6. Institute of Clinical Sciences Sahlgrenska Academy at University of Gothenburg Gothenburg Sweden

7. Sachska Pediatric Hospital Södersjukhuset Stockholm Sweden

8. Department of Clinical Sciences Pediatric Autoimmunity Lund University Lund Sweden

9. Skåne University Hospital Lund Sweden

10. Department of Pediatrics University Hospital Örebro Sweden

11. Department of Pediatrics Helsingborg Central Hospital Helsingborg Sweden

12. Department of Pediatrics Västerås Central Hospital Västerås Sweden

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Immunotherapies for Type 1 Diabetes;Textbook of Diabetes;2024-01-12

2. Verapamil improves One-Year C-Peptide Levels in Recent Onset Type-1 Diabetes: A Meta-Analysis;Indian Journal of Endocrinology and Metabolism;2023

3. Vitamin D and Beta Cells in Type 1 Diabetes: A Systematic Review;International Journal of Molecular Sciences;2022-11-20

4. Glutamic acid decarboxylase immunotherapy for type 1 diabetes;Current Opinion in Endocrinology, Diabetes & Obesity;2022-07-02

5. Immune response differs between intralymphatic or subcutaneous administration of GAD‐alum in individuals with recent onset type 1 diabetes;Diabetes/Metabolism Research and Reviews;2021-10-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3